PND39 - Cost Effectiveness Of Ivacaftor And Lumacaftor Combination For The Treatment Of Patients With Cystic Fibrosis In The United States
| Autor: | Sharma, D, Xing, S, Hung, Y, Caskey, RN, Dowell, ML, Touchette, DR |
|---|---|
| Zdroj: | In Value in Health November 2016 19(7):A431-A432 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect